Evidence map›Paper›PMID 40235688›Full record

ArticleCureus2025

A Novel Three-Dimensional Stereoscopic Navigation System for Laparoscopic Anatomic Liver Resection.

Kotaro Ito, Takao Ide, Tomokazu Tanaka, Hirokazu Noshiro

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kotaro ItoDepartment of Surgery, Saga University, Saga, JPN.
Takao IdeDepartment of Surgery, Saga University, Saga, JPN.
Tomokazu TanakaDepartment of Surgery, Saga University, Saga, JPN.
Hirokazu NoshiroDepartment of Surgery, Saga University, Saga, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCompared to viewing three-dimensional (3D) reconstructed images in a planar format, visualizing them in stereoscopic 3D using virtual reality technology enables intuitive and rapid recognition of spatial relationships. 3D stereoscopic navigation systems are expected to enhance the safety of liver resection by facilitating the precise localization of tumors and blood vessels. We recently introduced a novel 3D stereoscopic navigation system that allows real-time stereoscopic display of 3D simulations from any directional view selected by the attending surgeons during procedures. No reports have described the surgical advantages of the 3D stereoscopic navigation system in laparoscopic liver resection. In the present study, we retrospectively analyzed the usefulness of this novel 3D stereoscopic navigation system during laparoscopic anatomic liver resection (LALR).

methodsForty-four patients who underwent LALR from January 2021 to September 2023 were enrolled in this study. The patients were divided into two groups, each comprising 22 patients who underwent surgery with or without the current 3D stereoscopic navigation system. To determine the advantages of the navigation system, the perioperative surgical results and accuracy of the excised liver volume were compared between the two groups.

resultsThe patients' characteristics were not significantly different between the two groups. The estimated blood loss volume in the group with 3D stereoscopic navigation was significantly lower than that in the group without 3D stereoscopic navigation (118 vs. 218 mL, respectively; p = 0.048). There were no significant differences in the other surgical results between the two groups.

conclusionThe use of this novel 3D stereoscopic navigation system reduces intraoperative blood loss and facilitates precise anatomical identification during LALR.

Indexed as

3dblood losslaparoscopic anatomic liver resectionnavigationthree-dimensionalthree-dimensional stereoscopic navigation

Identifiers

PMID40235688
PMCPMC11999386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.